Result owner
Ask who reads each result.
After the first decision
Monitoring is part of the care, not an add-on
A plan needs a way to check both response and harm.
Checklist
Checks named in the label
The label gives prescribers a framework.
Blood sugar
The label calls for a check before treatment and repeat checks during care.
IGF-1
The label calls for blood tests of IGF-1, which rises with growth hormone, during treatment.
Eye health with diabetes
People with diabetes need watching for new or worse eye damage.
Response
The label says to weigh the benefit and risk again if deep belly fat does not fall.
Cancer history
Past cancer needs careful review, and active cancer rules treatment out.
Compare
Build a follow-up loop
The practical details matter.
Response time
Ask how and when results are shared.
Change point
Ask which finding would change the plan.
Between-visit questions
Ask how a new symptom or medicine gets reviewed.
Local care
Ask where an exam or urgent assessment would happen.
Read next
Useful official links
These are for label details and reporting, not for personal diagnosis.
- Current FDA label on DailyMed
Read the caution and interaction sections with the prescriber.
- FDA MedWatch
Patients can report a medicine problem directly to FDA.
- FDA guide to needle disposal
“Sharps” means used needles and syringes. Ask the local care team how to handle this product’s own supplies.